Chronic myeloid leukaemia to affect five times as many Australians and take three times as many lives by 2035
Friday September 20 2019
A recent report released by the Leukaemia Foundation has found more than five times as many Australians will be diagnosed with chronic myeloid leukaemia come 2035, and the number of Australians losing their life to the rare blood cancer will more than triple.
The report shows
Swab a cheek to save a life, this World Marrow Donor Day
Friday September 20 2019
Every year, more than 600 Australians living with blood cancer will need an allogeneic stem cell transplant to survive.
To access that life-saving treatment, some patients will find a stem cell donor within their own family. However, 70 per cent rely on a complete stranger to donate
Bridgestone network reaffirms Leukaemia Foundation support through new funding initiative
Wednesday 18 September 2019
Australia’s most trusted tyre brand, Bridgestone, and its nation-wide network of Bridgestone retail stores, has announced a three-year extension with long-term charity partner, the Leukaemia Foundation. The declaration coincides with the launch of a new way for
World Awareness Day for Australia’s most common blood cancer
Sunday 15 September 2019
A recent report released by the Leukaemia Foundation has revealed the true size and impact of the blood cancer lymphoma in Australia is far greater than was previously known.
The report shows currently around 6500 Australians will be diagnosed every year with a lymphoma making it Australia’s most common
Leukaemia Foundation shines spotlight on National MPN Awareness Day today
The Leukaemia Foundation is today honoring Australians living with the rare blood disorder Myeloproliferative Neoplasms (MPNs) as part of National MPN Awareness Day.
MPNs are just some of the many rare blood disorders which are seeing a rise in incidence, prevalence and mortality. More than 1205 Australians are diagnosed with
New national report reveals impact of blood cancer
Sunday 1 September 2019
A first-of-its-kind nationwide report commissioned by the Leukaemia Foundation reveals the true size, scale and impact of blood cancer and the lived experiences of people living with blood cancer in Australia today.
The Leukaemia Foundation has today marked the start of Blood Cancer
Local legacy to help fund blood cancer researchers of tomorrow
Friday 23 August 2019
A generous legacy by the family of a Cleveland local will help the Leukaemia Foundation support the next generation of Australian blood cancer researchers.
Cor Frederik (10.9.1927 – 25.9.2017) was businessman, scholar, author, investor, art collector and company director with a flourishing accounting practice in Cleveland, a
Leukaemia Foundation to support award for world leading haematologists
Wednesday 21 August 2019
Two world leaders in haematology will receive awards supported by the Leukaemia Foundation at this year’s International Society of Experimental Haematology Honorific (ISEH) meeting this week.
Dr David Scadden and Dr David Traver will be presented at ISEH’s Annual Scientific Meeting to be held in Brisbane from
Million-dollar investment into incurable blood cancer announced as Light the Night launches this week
Tuesday 6 August 2019
The Leukaemia Foundation will unveil a million-dollar investment into Strategic Ecosystem Research Partnership (SERP) grants which will use new state-of-the-art immunotherapy techniques, new drug design and molecular technology to understand the mechanisms of relapse and continue to drive rapid advancements in treatments for the incurable blood cancer, myeloma.
CAR-T therapy now accessible in Victoria for young Australians with acute lymphoblastic leukaemia at no cost
Monday 5 August 2019
The Leukaemia Foundation has welcomed the announcement by Federal Health Minister Greg Hunt and Victorian Minister for Health Jenny Mikakos to collaborate and co-fund CAR-T therapy in Victoria. The treatment will be available immediately and at no cost for paediatric and young adult patients up to 25 years of age with B-cell precursor acute lymphoblastic leukaemia (ALL) that